Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Beta Drugs IPO.
April 17, 2024 10:40:00 PM
Instead, a more efficient means of measuring volatility is by using a stock�s beta as a proxy � the higher the beta ... 20% below their initial opening price and 36% below their post-IPO high. Now may ...
Published by : NasdaqApril 26, 2024 11:56:00 AM
Chinese tech giant ByteDance has said it has no plans to sell TikTok after a new US law put it on a deadline to divest from the hugely popular video platform or have it banned in the United States. US ...
Published by : ????? ??????April 10, 2024 1:34:00 PM
U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...
Published by : U.S. News & World ReportApril 25, 2024 2:05:00 PM
Investors appear to be losing patience with Big Tech's prodigious artificial intelligence investments this week after Meta Platforms signaled deeper spending and a long road to profitability. The ...
Published by : ????? ??????April 12, 2024 11:10:00 AM
Meanwhile, the IPC has also warned that beta-blockers (metoprolol, propranolol and atenolol) used for various cardiac events can trigger temporary erectile dysfunction.
Published by : The Financial Express on MSNApril 9, 2024 10:45:00 AM
Follow live ...
Published by : The Guardian on MSNThe issue of Beta Drugs Limited opens on Sep 29, 2017 and closes for subscription on Oct 04, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 85.
Beta Drugs Limited is entering in the capital market with an IPO of 229,600 Equity Shares of Rs 10 aggregating up to Rs 1.95 Cr. The price band for the issue has been fixed at Rs 85.
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The issue opens on Sep 29, 2017 and closes for subscription on Oct 4, 2017. The equity shares of the company to be list at NSE SME platform.
The Beta Drugs IPO is proposed to open on September 29, 2017. The IPO application ends on October 4, 2017.
Retail investors can apply in the retail or non-institutional investor category from September 29, 2017 to October 4, 2017. The Beta Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Beta Drugs IPO will open for subscription on September 29, 2017. The public issue will close on October 4, 2017.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
